Rxo (RXO) Net Cash Flow (2021 - 2026)

Rxo (RXO) has 6 years of Net Cash Flow data on file, last reported at $4.0 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow rose 120.0% year-over-year to $4.0 million; the trailing twelve-month figure through Mar 2026 stood at $5.0 million (down 50.0% YoY), and the FY2025 full-year result was -$19.0 million, down 159.38% from the prior year.
• Net Cash Flow for Q1 2026 stood at $4.0 million, up from -$8.0 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $166.0 million in Q2 2022 and bottomed at -$100.0 million in Q4 2023.
• The 5-year median for Net Cash Flow is $2.0 million (2024), against an average of -$375000.0.
• The widest annual swing landed in 2022, when Net Cash Flow slumped 8600.0%; it then soared 352.63% in 2024.
• A 5-year view of Net Cash Flow shows it stood at -$87.0 million in 2022, then retreated by 14.94% to -$100.0 million in 2023, then surged by 82.0% to -$18.0 million in 2024, then soared by 55.56% to -$8.0 million in 2025, then jumped by 150.0% to $4.0 million in 2026.
• The last three Net Cash Flow figures came in at $4.0 million (Q1 2026), -$8.0 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.

Peer Comparison